Akebia Therapeutics Inc. buy Jefferies Financial Group Inc.
Start price
01.04.25
/
50%
€1.85
Target price
01.04.26
€5.54
Performance (%)
-36.32%
End price
02.04.26
€1.18
Summary
This prediction ended on 02.04.26 with a price of €1.18. The BUY prediction by Jefferies_Financial_ for Akebia Therapeutics Inc. performed very badly with a performance of -36.32%. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akebia Therapeutics Inc. | -32.313% | -32.313% | -72.653% |
| iShares Core DAX® | 0,44 % | 5,90 % | 8,05 % |
| iShares Nasdaq 100 | 1,06 % | 0,92 % | 28,47 % |
| iShares Nikkei 225® | 1,77 % | 1,23 % | 47,57 % |
| iShares S&P 500 | 0,37 % | 1,92 % | 23,20 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $6.00 price target on the stock.
Ratings data for AKBA provided by MarketBeat
In the thread Trading Akebia Therapeutics Inc.
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten